10

DRUG4 trials

Sponsors

Ziekenhuis Aan De Stroom, Universitaetsklinikum Schleswig-Holstein, Rheinische Friedrich-Wilhelms-Universitaet Bonn

Conditions

Overweight or ObesityPolycystic Ovary Syndrome (PCOS)Prostate canceracute lymphoblastic leukemia in children and adolescents

Phase 2

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial

RecruitingCTIS2022-501551-90-00

Ziekenhuis Aan De StroomProstate cancer

Start: 2023-12-13Target: 583Updated: 2026-01-23

A phase II, randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) with LHRH agonist or antagonist versus anti-androgen therapy (AAT) with apalutamide in patients with biochemical progression after radical prostatectomy

Not yet recruitingCTIS2024-512023-37-00

Ziekenhuis Aan De StroomProstate cancer

Target: 202Updated: 2025-09-11

Phase 3

AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

Active, not recruitingCTIS2023-509856-32-00

Universitaetsklinikum Schleswig-Holsteinacute lymphoblastic leukemia in children and adolescents

Start: 2018-07-15Target: 4250Updated: 2025-08-19

Phase 4

A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS)

RecruitingCTIS2024-515982-32-00

Rheinische Friedrich-Wilhelms-Universitaet BonnOverweight or Obesity, Polycystic Ovary Syndrome (PCOS)

Start: 2025-12-09Target: 198Updated: 2025-10-06